Hemodialysis. Care involving dialysis
Conditions
Interventions
Intervention 1: On the first day of the study (before the intervention), the pain from the fistula needle will be measured and recorded.
Experimental group: experimental group will be exposed to the
Treatment - Drugs
On the first day of the study (before the intervention), the pain from the fistula needle will be measured and recorded.
Experimental group: experimental group will be exposed to the inhalation of
Control group: Patients in the control group will be treated by the above method under aromatherapy with placebo. The placebo is produced by Barij Essence Company and include a base combination of an
Sponsors
Vice Chancellor for research Mazandaran University of Medical Sciences.
Eligibility
Sex/Gender
All
Age
18 Years to 130 Years
Inclusion criteria
Inclusion criteria: Patient including major criteria; 3 times a week dialysis; being over 18; alertness and ability to communicate and having a good sense of smell. Patient eligibility major criteria; candidate for a transplant; pregnancy; record of allergies; chronic respiratory diseases; using analgesic in 3 hours and drug addiction
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The pain from the fistula needle. Timepoint: Before intervention and after 3 interventions. Method of measurement: Visual Pain Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Allergic to Lavender. Timepoint: To 6 days after the first intervention. Method of measurement: Side effects of the drug and the patient's questions. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Mohamad Ali Heydari Gorji
Mazandaran University of Medical Science
Outcome results
None listed